Grants and Contributions:
Title:
Accelerating Manufacturing Quality and Clinical Performance of Cell Therapies
Agreement Number:
972290
Agreement Value:
$217,500.00
Agreement Date:
May 10, 2021 - Mar 31, 2024
Description:
The firm will manufacture its cell conditioning product and use it to develop proof-of-concept (PoC) studies for its clients. Success of this objective will lead to R&D contracts and licensing agreements between parties.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H4S 1Z9
Reference Number:
172-2021-2022-Q1-972290
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
775533284
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 60 days.
Amendment Date
Jan 9, 2024
Recipient's Legal Name:
TARGA BIOMÉDICALE INC. / TARGA BIOMEDICAL INC.
Federal Riding Name:
Saint-Laurent
Federal Riding Number:
24068
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: